DCLK1 and pancreatic neoplasm: Particularly, KDM3A has been reported to enhance the expression of DCLK1 with the removal of di‐ and mono‐methyl residues from H3K9me2/me1, and their high expression in pancreatic cancer tissues was correlated with shorter survival times of patients.21